Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan
Clinical trial NCT03063710 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03063710
- Sponsor
- AstraZeneca
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.